Archives for June 2012

SENSITIZING TRIPLE NEGATIVE BREAST CANCER’S (TNBC’S) TO RADIATION THERAPY

This diet plan was designed for a woman with triple negative breast cancer (TNBC). The patient had her tumors removed but was unable to complete her chemotherapy regime so her oncologist prescribed external beam radiation treatments. We designed… [Learn More…]

Lenalidomide For Multiple Myeloma

Lenalidomide is a derivative of the notorious anti-nausea drug Thalidomide, but does not share the same toxicity of Thalidomide. Recent data shows that Lenalidomide maintenance therapy prolongs the time to disease progression after autologous… [Learn More…]

Dacomitinib For EGFR Inhibitor Resistant NSCLC`s

Dacomitinib is one of the latest advances in treatment of EGFR mutant NSCLC’s that have become resistant to reversible EGFR tyrosine kinase inhibitors. Dacomitinib differs from other EGFR inhibitors in that it irreversibly inhibits EGFR, HER2 and… [Learn More…]